Imaging News and Research

RSS

Oxford study identifies brain mechanisms behind our sense of control

A study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.

21 Aug 2026

New review highlights spatial technologies in advanced brain mapping

Understanding how molecular changes shape brain function and disease requires more than measuring genes in bulk tissue.

21 Aug 2026

Antibodies for visualizing cell identity and tumor architecture

Whether you are characterizing cell state transitions, assessing organelle integrity, or building a multiplex immunofluorescence (IF) assay, you need reliable structural markers for your imaging.

From Antibodies Incorporated 21 Aug 2026

Cryo-EM provides real-time glimpse of cellular machinery reading DNA inside living organisms

All living things have a fleet of tiny copy machines that turn instructions from DNA into RNA, the molecules responsible for helping build proteins that keep organisms alive.

20 Aug 2026

Scientists uncover safer way to tame cancer cell senescence

Stopping tumor growth is only half the battle. Rather than kill tumor cells, many cancer therapies can only push them into cellular senescence, a state in which cells stop dividing but do not die. These "undead" cells will continue to release signals that reshape the tumor environment.

20 Aug 2026

Wake-activated brain circuits reveal what drives the urge to sleep

Researchers identified wake-activated neurons in the median raphe and anterior medial preoptic area that track sleep pressure and help regulate when and how deeply mice sleep. Manipulating these circuits altered NREM sleep, sleep-pressure accumulation, and rebound sleep, revealing key neural mechanisms underlying mammalian sleep homeostasis.

20 Aug 2026

Psilocybin may make the brain more organized than scientists expected

In 62 adults, researchers combined fMRI, EEG and machine learning to examine how psilocybin reshapes brain activity during rest, meditation, music and movie viewing. They found that context-sensitive neural organization tracked the intensity and quality of psychedelic experiences and was associated with next-day mindset change.

20 Aug 2026

New AI framework improves reliability of cancer pathology diagnosis

Cancer diagnoses directly affect treatment decisions and prognosis and can even have life-altering consequences.

20 Aug 2026

Study: Nearly 8 out of 10 young adults have cardiovascular-kidney-metabolic syndrome

A new scientific study found that nearly 8 out of 10 young adult participants, average age 23 years, had cardiovascular-kidney-metabolic syndrome (CKM syndrome), according to new independent research published today in Circulation: Population Health and Outcomes, a peer-reviewed scientific journal of the American Heart Association.

20 Aug 2026

Review examines how medical imaging foundation models are moved toward clinical use

AI is already widely used for lesion detection, disease classification, and outcome prediction in medical imaging, but most systems remain narrowly designed for one task and depend heavily on expert-labelled data.

20 Aug 2026

Scintica and Indus Instruments introduce PulSAR MD: An integrated M-Mode and Doppler data acquisition system with powerful automatic analysis

Scintica and Indus Instruments are proud to introduce PULSAR MD (Preclinical Ultrasound for Small Animal Research M-Mode and Doppler) system, the next evolution in preclinical hemodynamic assessment.

From Scintica Instrumentation Inc. 20 Aug 2026

Vibration isolation in drug discovery research

Vibration isolation supports high-resolution microscopy in drug discovery, enabling stable imaging environments and reliable data at the nanometer scale.

From TMC Vibration Control 20 Aug 2026

FDA-cleared medical AI rarely tested for real-world benefits

A new analysis shows that, of 1,357 artificial intelligence (AI)-based medical devices authorized by the U.S. Food and Drug Administration (FDA) for use in patient care, only three had been tested on whether they actually improve patients' health.

20 Aug 2026

Two distinct types of brain tissue work together to support cognition in older adults

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have found that two distinct types of brain tissue work together to support cognition in older adults, and that the health of the brain's short-range wiring may help soften the cognitive effects of gray matter loss.

20 Aug 2026

New AI spots hypertrophic cardiomyopathy obstruction from standard ultrasounds

Mayo Clinic researchers have developed and externally validated an artificial intelligence (AI) model that can identify a potentially significant heart obstruction from routine ultrasound videos without relying on specialized Doppler imaging.

19 Aug 2026

World's largest single-site study maps brain changes under psilocybin

A landmark five-year study by Monash University has found psychedelics reorganise brain patterns, giving clinicians powerful new insights into their therapeutic potential.

19 Aug 2026

Real-world study shows Oregon psilocybin services relieve mental health symptoms

People participating in an Oregon Health & Science University-led study of state-regulated psilocybin services reported relief from symptoms of anxiety, depression and post-traumatic stress disorder - with almost two-thirds declaring the experience to be among the most meaningful of their life.

19 Aug 2026

Gene editing fails to protect beta-cell transplants from rejection

In people with type 1 diabetes, the immune system mistakenly destroys the pancreatic beta cells responsible for producing insulin. Patients therefore require lifelong insulin therapy to regulate their blood glucose levels.

19 Aug 2026

Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model

Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced the opening of its new office space in London, UK.

From Qureight 19 Aug 2026

Brain changes detect Alzheimer's seven years before plaques appear

A new study suggests that Alzheimer's disease may be detected by brain imaging more than seven years earlier than previously assumed. Researchers from the Department of Psychology at the University of Oslo led the study, published in Nature Neuroscience.

19 Aug 2026